SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis

doi:10.3748/wjg.v21.i27.8398

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7786)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-8) series.

Item

Count

PDF

496

WORD

262

HTML

4005

Figures (1-5)

131

Tables (1-8)

133

Sum=5027

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1015

Download

1744

Sum=2759

Jul 21, 2015 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Jul 21, 2015; 21(27): 8398-8407
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8398

Table 7 Univariate analysis of factors influencing disease-free survival in 402 patients with gastrointestinal stromal tumor

Factor		5-yr DFS rate (%)	DFS HR (95%CI)	P value
Gender	Male: Female	69.0: 69.7	0.643 (0.398-1.038)	0.071
Age (yr)	≤ 60: > 60	72.1: 65.6	1.285 (0.806-2.049)	0.292
Gastrointestinal bleeding	No: Yes	71.6: 65.7	1.425 (0.874-2.322)	0.155
Primary tumor site	Gastric: Non-gastric	81.5: 59.4	2.669 (1.623-4.388)	0.001¹
Predominant cell type	Spindle: Epithelioid: Mixed	72.0: 67.1: 71.3	0.877 (0.661-1.164)	0.365
Primary tumor size (cm)	≤ 5: > 5	92.2: 50.8	8.183 (3.921-17.079)	< 0.001¹
Mitotic index (HPFs)	≤ 5/50: 6-10/50: > 10/50	84.2: 50.7: 19.0	3.289 (2.545-4.253)	< 0.001¹
NIH stage	Very low: Low: Mid: High	100.0: 93.3: 87.1: 40.0	5.421 (3.249-9.045)	< 0.001¹
SLITRK3 expression	(-): (+): (++): (+++)	91.7: 78.6: 71.6: 41.8	2.082 (1.575-2.753)	< 0.001¹

¹Statistically significant (P < 0.01). Mid: Intermediate; DFS: Disease-free survival.

Citation: Wang CJ, Zhang ZZ, Xu J, Wang M, Zhao WY, Tu L, Zhuang C, Liu Q, Shen YY, Cao H, Zhang ZG. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis. World J Gastroenterol 2015; 21(27): 8398-8407
URL: https://www.wjgnet.com/1007-9327/full/v21/i27/8398.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i27.8398